Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor/ Broker meetings to be conducted. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meetings to be conducted. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith a copy of advertisement published in today''s newspaper regarding Postal Ballot Notice and e-voting information. The same is also available on website of the Company at www.alkemlabs.com. Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith. Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In furtherance to our intimation dated 09th February, 2024 and pursuant to the applicable provisions of the Companies Act, 2013 and SEBI (LODR) Regulations, 2015, please find attached herewith the Postal Ballot Notice dated 09th February, 2024 for the business as specified in the said notice. Kindly take the same on your records. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to inform you that US FDA has issued an Establishment Inspection Report (EIR) with respect to the inspection conducted at the Company''s API manufacturing facility at Mandva and the inspection has now been closed. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Clarification With Respect To Increase In The Volume Of Security Across The Exchange.
With reference to your email received dated 27th February, 2024, we would like to inform you that the Company is in compliance with the provisions of SEBI Listing Regulations. Alkem Laboratories Ltd - 539523 - Clarification sought from Alkem Laboratories Ltd
The Exchange has sought clarification from Alkem Laboratories Ltd on February 27, 2024, with reference to Movement in Volume. The reply is awaited. Alkem clarifies on tax evasions reports
The drugmaker's stocks had fallen about 14 per cent on Monday, following source-based reports alleging tax evasion Alkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 As Amended With Respect To News Articles Published By The Press/Media.
Please find enclosed herewith the clarification letter with respect to news articles published by the press/ media.